Tango Therapeutics, Inc. (TNGX) /
The revenue of Tango Therapeutics, Inc. over the past 6 years
Chart Tango Therapeutics, Inc.: revenue, fiscal 2020–2025 Open the chart →Tango Therapeutics, Inc. reported revenue of $62.38M in fiscal 2025, the latest fiscal year on file. In fiscal 2020 it was $7.66M — up 715% over 5 years. Year over year, revenue rose 4 times and fell once. The largest one-year move was in fiscal 2021: up 384%, from $7.66M to $37.04M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $62.38M |
| 2024ended Dec 31, 2024 | $42.07M |
| 2023ended Dec 31, 2023 | $36.53M |
| 2022ended Dec 31, 2022 | $24.86M |
| 2021ended Dec 31, 2021 | $37.04M |
| 2020ended Dec 31, 2020 | $7.66M |
Fiscal years as Tango Therapeutics, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Tango Therapeutics, Inc.
- The profitability of Tango Therapeutics, Inc.
- The cash flow of Tango Therapeutics, Inc.
- The debt of Tango Therapeutics, Inc.
- All of Tango Therapeutics, Inc.'s financials, charted
Companies of a similar size
- MWAMueller Water Products, Inc.
- TNETTRINET GROUP, INC.
- PRIMPrimoris Services Corporation
- BNLBroadstone Net Lease, Inc.
- SMGScotts Miracle-Gro Co
Not investment advice. This page shows what Tango Therapeutics, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.